Home
About
The project
Objectives
Benefits
First Year Project Results
Second Year Project Results
Third year project results
Partners
Results & Public Documents
Public documents
Project Dissemination material
Newsletter
News & Events
News
Events
Dissemination & Communication report
Contact us
Partner area
Home
About
The project
Objectives
Benefits
First Year Project Results
Second Year Project Results
Third year project results
Partners
Results & Public Documents
Public documents
Project Dissemination material
Newsletter
News & Events
News
Events
Dissemination & Communication report
Contact us
Partner area
Objectives
BIOBESTicide objectives are:
To build a DEMO plant producing 10T of high-quality oomycete-based biopesticide product per year to be used in viticulture
To design the optimal product formulation to deliver
Pythium oligandrum
strain I-5180 and optimise the efficiency of the products
To manage the logistics solutions of the whole process to minimise losses and reduce costs associated
To test the products in controlled environments and practice conditions to demonstrate the performance of the product. In parallel, to monitor any unintended impact on the environment and potential risks for human health
To comply with the European regulation on Plant Protection Product (PPP) and to submit an approval dossier in order to obtain an authorisation for marketing the product
To ensure the sustainability of the established value chain
To demonstrate and showcase to relevant stakeholders the feasibility of the
oligandrum
-based biopesticide producing value chain; to involve specific categories of interest in the project such as farmers, companies involved in harvesting, storage and transportation of biomass, vinery companies, policy makers, researchers and society
This project has received funding from the Biobased Industries Joint Undertaking (JU) under the European Union’s Horizon 2020 research and innovation programme under grant agreement N° 886776. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and the Bio-based Industries Consortium.